Back to Results
First PageMeta Content
Gynaecological cancer / Gender transitioning / Hysterectomy / Surgical oncology / Uterine fibroid / Uterine myomectomy / Uterine sarcoma / Laparoscopic surgery / Gynaecology / Medicine / Gynecological surgery / Benign neoplasms


Statement of the Society of Gynecologic Oncology to the Food and Drug Administration’s Obstetrics and Gynecology Medical Devices Advisory Committee Concerning Safety of Laparoscopic Power Morcellation
Add to Reading List

Document Date: 2014-07-11 17:23:10

Open Document

File Size: 49,93 KB

Share Result on Facebook

Country

France / Japan / United States / Brazil / India / /

IndustryTerm

surgical tools / routine preoperative imaging / /

MedicalCondition

cancers / uterine cancer / unsuspected sarcoma / uterine sarcomas / cancer / gynecologic cancers / notably uterine sarcoma / venous thrombosis / fibroids / incidental sarcoma / pulmonary compromise / surgical site infection / occult sarcoma / sarcoma / pain / benign fibroids / symptomatic fibroids / gynecologic cancer / otherwise benign-appearing symptomatic fibroids / uterine sarcoma / uterine fibroids / /

MedicalTreatment

hysterectomies / Hysterectomy / Minimally invasive surgery / surgery / /

Organization

Obstetrics and Gynecology Medical Advisory Committee / Food and Drug Administration / American Cancer Society / Society of Gynecologic Oncology / /

URL

www.sgo.org/newsroom/positionstatements-2/morcellation / /

SocialTag